![Jos Raats](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Jos Raats
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Citryll BV
![]() Citryll BV Miscellaneous Commercial ServicesCommercial Services Citryll BV is a private pharmaceutical company located in Oss, the Netherlands, at the Pivot Park. Citryll is dedicated to developing and commercializing therapeutics that target netosis and NETs, with a focus on immune-mediated inflammatory diseases. The Dutch company's lead antibody, Cit-013, has a unique dual mode of action and proprietary NET biomarker assays, making it a promising drug for rheumatoid arthritis and hidradenitis suppurativa. The initial clinical trials with Cit-013 are expected to provide the foundation for a new treatment paradigm for immune-mediated inflammatory diseases. The company was founded in 2015 by Helmuth van Es, Renato Chirivi, and the late Jos Raats of ModiQuest. | Directeur/Bestuurslid | - | - |
Loopbaan van Jos Raats
Eerdere bekende functies van Jos Raats
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Immunoprecise Antibodies (Europe) BV
![]() Immunoprecise Antibodies (Europe) BV Pharmaceuticals: MajorHealth Technology Immunoprecise Antibodies (Europe) BV operates as a pharmaceutical company that specializes in antibiotics. Its services include antigen selection, antibody generation, antibody optimization, antibody production, antibody processing and assay development. The company was founded in 2004 and is headquartered in Oss, the Netherlands. | Algemeen Directeur | 01-01-2005 | 15-03-2019 |
President | 01-01-2005 | 15-03-2019 |
Statistieken
Internationaal
Nederland | 3 |
Operationeel
Chief Executive Officer | 1 |
President | 1 |
Director/Board Member | 1 |
Sectoraal
Health Technology | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Immunoprecise Antibodies (Europe) BV
![]() Immunoprecise Antibodies (Europe) BV Pharmaceuticals: MajorHealth Technology Immunoprecise Antibodies (Europe) BV operates as a pharmaceutical company that specializes in antibiotics. Its services include antigen selection, antibody generation, antibody optimization, antibody production, antibody processing and assay development. The company was founded in 2004 and is headquartered in Oss, the Netherlands. | Health Technology |
Citryll BV
![]() Citryll BV Miscellaneous Commercial ServicesCommercial Services Citryll BV is a private pharmaceutical company located in Oss, the Netherlands, at the Pivot Park. Citryll is dedicated to developing and commercializing therapeutics that target netosis and NETs, with a focus on immune-mediated inflammatory diseases. The Dutch company's lead antibody, Cit-013, has a unique dual mode of action and proprietary NET biomarker assays, making it a promising drug for rheumatoid arthritis and hidradenitis suppurativa. The initial clinical trials with Cit-013 are expected to provide the foundation for a new treatment paradigm for immune-mediated inflammatory diseases. The company was founded in 2015 by Helmuth van Es, Renato Chirivi, and the late Jos Raats of ModiQuest. | Commercial Services |